Concomitant levocetirizine and montelukast in the treatment of seasonal allergic rhinitis: Influence on clinical symptoms

Italian Journal of Allergy and Clinical Immunology

Volumn 16, Issue 2, 2006, Pages 63-68

  Lombardo, Giuseppe ^a,b   Quattrocchi, P ^a   Lombardo, G R ^a   Galati, P ^a   Giannetto, L ^a   Barresi, L ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b NONE   (Italy)

Author keywords

Levocetirizine; Montelukast; Seasonal allergic rhinitis

Indexed keywords

HISTAMINE; LEVOCETIRIZINE; MONTELUKAST; PEPTIDOLEUKOTRIENE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EOSINOPHIL COUNT; FEMALE; HAY FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE CONGESTION; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RHINOCONJUNCTIVITIS; RHINORRHEA; SCORING SYSTEM; SNEEZING; SYMPTOMATOLOGY; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 33750712425     PISSN: 11206373     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Togias A. Unique mechanistic features of allergic rhinitis. J Allergy Clin Immunol 2000;105:S 599-S 604.
2. Bousquet J, Vignola AM, Campbell AM, Michel FB. Pathophysiology of allergic rhinitis. Int Arch Allergy Immunol 1996;110:207-18.
3. Skoner DP, Lee L, Doyle WJ, Boehm S, Fireman P. Nasal physiology and inflammatory mediators during natural pollen exposure. Ann Allergy 1990;65:206-10.
4. American thoracic society workshop. Immunobiology of asthma and rhinitis: pathogenic factors and therapeutic options. AM Respir Crit Care Med 1999;160:1778-87.
5. Duchateau J, Heenen M, Sternon J. H1 histamine antagonists. Rev Med Brux 2003;24:95-100.
6. 1-antihistamines in humans. Clin Allegy Immunol 2002; 17:101-39.
7. Juniper EF. Measuring healt-related quality of life in rhinitis. J Allergy Clin Immunol 1997;99:S742-9.
8. Thompson AK, Juniper E, Meltzer EO. Quality of life in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2000;85:338-47.
9. Fireman P. Treatment strategies designed minimize medical complications of allergic rhinitis. Am J Rhinol 1997;11:95-102.
10. Suonpaa J. Treatment of allergic rhinitis. Ann Med 1996;28:17-22.
11. Marshall GD Jr. Therapeutic options in allergic disease: antihistamines as systemic antiallergic agents. J Allergy Clin Immunol 2000;106(Suppl 5):S306-9.
12. Klimek L. Potential of Levocetirizine in the relief of nasal congestion. Int J Clin Pract 20055;59:721-9.
13. Holgate S, Powell R, Jenkins M, Ali O. A treatment for allergic rhinitis: a view on the role of Levocetirizine. Curr Med Res Opin 2005;21:1099-106.
14. Leynaidir F, Mees K, Arendt C, Pinelli ME. Efficacy and safety of Levocetirizine in seasonal allergic rhinitis. Acta Otorhinolaryngol Belg 2001;55:305-12.
15. Hussein Z, Pitsiu M, Majid O, Aarons L, de Longueville M, Stockis A, ETAC Study Group. Retrospective population pharmacokinetics of Levocetirizine in atopic children receving cetirizine: The ETAC study. Br J Clin Pharmacol 2005;59:28-37.
16. Okuda M, Watase T, Mezawa A, Liu CM. The role of leukotriene D4 in allergic rhinitis. Ann Allergy 1988;60-537-40.
17. Donnelly AL, Glass M, Minkwitz MC, Casale TB. The leukotriene D4-receptor antagonist, ICI 204, 219, relieves symptoms of acute seasonal allergic rhinitis. Am J Respir Crit Care Med 1995;151:1734-9.